MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2024-09-26 (thailand-business-news.com)
Medtronic to announce financial results for its second quarter of fiscal year 2024
DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial
Read more
2024-09-14 (marketwirenews.com)
ATEC Reports Second Quarter 2024 Financial Results...
Surgical revenue grew 27% and drove total revenue growth of 25% to $146 million Full-year revenue and profitability guidance increased Alphatec.
Read more
2024-02-06 (bangkokstyle.online)
Medtronic to announce financial results for its third quarter of fiscal year 2024
DUBLIN, Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial
Read more
2023-05-23 (startribune.com)
Analysts expect Medtronic to deliver frank financial answers this week
The company is investing more than $350 million, adding jobs in India during global belt-tightening.
Read more
2021-09-01 (medtronic.com)
Celebrating Earl Bakken | Medtronic
October 2018 - Medtronic co-founder Earl E. Bakken, a pioneer in medical technology whose inventions impacted the lives of millions of people around the world, passed away Sunday in Hawaii. He was 94 years old.
Read more
2018-09-17 (massdevice.com)
France suspends blood collection using Haemonetics devices
UPDATED Sept. 17, 2018, with comment from Haemonetics. The French government reportedly decided on a precautionary suspension of the use of a blood collection device made by Haemonetics (NYSE:HAE) – used in half of all donations there – after receiving numerous reports of problems with the devices.
Read more
(mpo-mag.com)
Shaun Blakeman Joins Intricon as Chief Financial Officer
The U.S. Navy veteran served in in senior financial positions at Medtronic and IDEX Corporation.
Read more